Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gwen Melincoff Insider Profile
4 Followers
Gwen Melincoff, Director at Tobira Therapeutics, holds 0.00 shares in Tobira Therapeutics (Ticker: TBRA), holds 44.77K shares in Collegium Pharmaceutical (Ticker: COLL), holds 666.00 shares in Soleno Therapeutics (Ticker: SLNO). Most recently, Gwen Melincoff ― shares of Tobira Therapeutics on ― for an estimated value of ―.
Gwen Melincoff Tobira Therapeutics (TBRA)Director
Tobira Therapeutics (TBRA)
Director
Not Ranked
Gwen Melincoff has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Gwen Melincoff holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 20, 2019 - Nov 20, 2020
Return:+29.20%
The most profitable trade made by Gwen Melincoff
Gwen Melincoff's Trading History
Tobira Therapeutics
―
―
―
$0.00
Collegium Pharmaceutical
May 19, 2023
Director
Uninformative Buy
―
$1.56M
Soleno Therapeutics
Nov 20, 2019
Director
Informative Buy
15.30K
$24.74K
Protalix
―
Director
―
―
Gain Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Gwen Melincoff's performance on stock
You May Also Like
Gwen Melincoff insider profile FAQ
What is the percentage of profitable transactions made by Gwen Melincoff?
The percentage of profitable transactions made by Gwen Melincoff is ―.
What is the average return per transaction made by Gwen Melincoff?
The average return per transaction made by Gwen Melincoff is ―.
What stocks does Gwen Melincoff hold?
Gwen Melincoff holds: TBRA, COLL, SLNO, PLX, GANX stocks.
What was Gwen Melincoff’s latest transaction?
Gwen Melincoff latest transaction was an Uninformative Buy of ―.
What was Gwen Melincoff's most profitable transaction?
Gwen Melincoff’s most profitable transaction was an Informative Buy of SLNO stock on November 20, 2019. The return on the trade was 29.20%.
What is Gwen Melincoff's role in Tobira Therapeutics?
Gwen Melincoff's role in Tobira Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.